Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

AVADEL PHARMACEUTICALS, PLC

Filed by LMH STRATEGIC SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-01 06:26:09 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Termination
Posted
Oct 19, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
39c74cd5-5094-4756-bb79-414756c654b2
Termination date
Jun 30, 2026

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request.

Literal federal measure citations: H.R.4692, S.574

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.